UNSPSC 51294210: Oxaflozane hydrochloride

This classification denotes an antidepressant agent with the molecular formula C14H18F3NO.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E10FW59D1I, chemically known as 4-isopropyl-2-(alpha,alpha,alpha-trifluoro-m-tolyl)morpholine hydrochloride but more generally known as oxaflozane hydrochloride, which bears US NIH Compound Identifier 167466. European Medicines Agency schedules Oxaflozane hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03560MIG.

Most nations, for tariff and trade purposes, schedule oxaflozane hydrochloride under HS 29349990 and SITC 51579. As of Q4 2014, OXAFLOZANE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CC(C)N1CCOC(C1)C2CCCC(C2)C(F)(F)F.CL.

UNSPSC 51294210 Oxaflozane hydrochloride is a Commodity code that in practice captures pharmaceutical procurement by state and local health agencies, though recent sourcing activity under this code does not reflect oxaflozane specifically. Seminole County, Florida has posted competitive bidding for naloxone and drug deactivation systems—opioid-reversal medications and related harm-reduction equipment—rather than oxaflozane, suggesting that state and local procurement offices may tag therapeutic-class pharmaceuticals and medical supplies under this code regardless of the specific active ingredient named in the code definition. County health departments and community health programs appear to be the primary users of this code tier when sourcing emergency response medications and overdose-treatment supplies.

Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, requesting annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The bidding window closed July 26, 2023 (the source contains a date inconsistency; the solicitation was posted in 2026 but the deadline reflects 2023). Bidders must include shipping and delivery costs in pricing, hold drug-free workplace certification and E-Verify compliance, and carry workers' compensation, commercial general liability, and professional liability insurance. The contract carries a two-year initial term with one-year renewal option and was potentially funded through FEMA, introducing federal compliance requirements including the Clean Air Act and Federal Water Pollution Control Act. The single recent opportunity posted under this code suggests low overall activity in state and local pharmaceutical sourcing at the Commodity level, or a significant mismatch between code definition and actual procurement classification in public-sector systems.